A study from the American Society of Hematology (ASH) Annual Meeting and Exposition presented by lead ... read more

According to data presented tonight at the American Society of Hematology (ASH) Annual Meeting and Exposition ... read more

Crizanlizumab was associated with a halved likelihood of priapic events among treated patients with sickle cell ... read more

According to data from the American Society of Hematology (ASH) Annual Meeting and Exposition, investigators were ... read more

A recent study presented at the American Society of Hematology (ASH) Annual Meeting and Exposition indicated ... read more

Red blood cell deformability is directly related to spleen filtration for pediatric patients with sickle cell ... read more

Data presented at the American Society of Hematology (ASH) Annual Meeting and Exposition showed the benefits ... read more

New data presented at the 2022 American Society of Hematology (ASH) Meeting show the use of ... read more